Recruitment of Human C1 Esterase Inhibitor Controls Complement Activation on Blood Stage Plasmodium falciparum Merozoites

被引:21
作者
Kennedy, Alexander T. [1 ,2 ]
Wijeyewickrema, Lakshmi C. [3 ]
Huglo, Alisee [1 ,2 ]
Lin, Clara [1 ,2 ]
Pike, Robert [3 ]
Cowman, Alan F. [1 ,2 ]
Tham, Wai-Hong [1 ,2 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
[3] La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3083, Australia
基金
英国医学研究理事会;
关键词
MALARIA PARASITE INVASION; FACTOR-H; SURFACE PROTEIN-3; HUMAN ERYTHROCYTES; SERINE-PROTEASE; IN-VITRO; BINDING; PATHWAY; VACCINE; C1-INHIBITOR;
D O I
10.4049/jimmunol.1700067
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement system is a front-line defense system that opsonizes and lyses invading pathogens. To survive, microbes exposed to serum must evade the complement response. To achieve this, many pathogens recruit soluble human complement regulators to their surfaces and hijack their regulatory function for protection from complement activation. C1 esterase inhibitor (C1-INH) is a soluble regulator of complement activation that negatively regulates the classical and lectin pathways of complement to protect human tissue from aberrant activation. In this article, we show that Plasmodium falciparum merozoites, the invasive form of blood stage malaria parasites, actively recruit C1-INH to their surfaces when exposed to human serum. We identified PfMSP3.1, a member of the merozoite surface protein 3 family of merozoite surface proteins, as the direct interaction partner. When bound to the merozoite surface, C1-INH retains its ability to complex with and inhibit C1s, MASP1, and MASP2, the activating proteases of the complement cascade. P. falciparum merozoites that lack PfMSP3.1 showed a marked reduction in C1-INH recruitment and increased C3b deposition on their surfaces. However, these Delta PfMSP3.1 merozoites exhibit enhanced invasion of RBCs in the presence of active complement. This study characterizes an immune-evasion strategy used by malaria parasites and highlights the complex relationship between merozoites and the complement system.
引用
收藏
页码:4728 / 4737
页数:10
相关论文
共 60 条
  • [1] Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen
    Audran, R
    Cachat, M
    Lurati, F
    Soe, S
    Leroy, O
    Corradin, G
    Druilhe, P
    Spertini, F
    [J]. INFECTION AND IMMUNITY, 2005, 73 (12) : 8017 - 8026
  • [2] Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation
    Avirutnan, Panisadee
    Hauhart, Richard E.
    Somnuke, Pawit
    Blom, Anna M.
    Diamond, Michael S.
    Atkinson, John P.
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 187 (01) : 424 - 433
  • [3] Human malaria in immunocompromised mice:: An in vivo model to study defense mechanisms against Plasmodium falciparum
    Badell, E
    Oeuvray, C
    Moreno, A
    Soe, S
    van Rooijen, N
    Bouzidi, A
    Druilhe, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (11) : 1653 - 1659
  • [4] Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver
    Bergamaschini, L
    Gobbo, G
    Gatti, S
    Caccamo, L
    Prato, P
    Maggioni, M
    Braidotti, P
    Di Stefano, R
    Fassati, LR
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (03) : 412 - 420
  • [5] C1 inhibitor potentiates the protective effect of organ preservation solution on endothelial cells during cold storage
    Bergamaschini, L
    Gatti, S
    Caccamo, L
    Prato, P
    Latham, L
    Trezza, P
    Maggioni, M
    Gobbo, G
    Fassati, LR
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 939 - 941
  • [6] Complement and Antibody-mediated Enhancement of Red Blood Cell Invasion and Growth of Malaria Parasites
    Biryukov, Sergei
    Angov, Evelina
    Landmesser, Mary E.
    Spring, Michele D.
    Ockenhouse, Christian F.
    Stoute, Jose A.
    [J]. EBIOMEDICINE, 2016, 9 : 207 - 216
  • [7] Complement evasion strategies of pathogens-Acquisition of inhibitors and beyond
    Blom, Anna M.
    Hallstrom, Teresia
    Riesbeck, Kristian
    [J]. MOLECULAR IMMUNOLOGY, 2009, 46 (14) : 2808 - 2817
  • [8] HUMAN C1BAR INHIBITOR - PRIMARY STRUCTURE, CDNA CLONING, AND CHROMOSOMAL LOCALIZATION
    BOCK, SC
    SKRIVER, K
    NIELSEN, E
    THOGERSEN, HC
    WIMAN, B
    DONALDSON, VH
    EDDY, RL
    MARRINAN, J
    RADZIEJEWSKA, E
    HUBER, R
    SHOWS, TB
    MAGNUSSON, S
    [J]. BIOCHEMISTRY, 1986, 25 (15) : 4292 - 4301
  • [9] Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development
    Boyle, Michelle J.
    Wilson, Danny W.
    Richards, Jack S.
    Riglar, David T.
    Tetteh, Kevin K. A.
    Conway, David J.
    Ralph, Stuart A.
    Baum, Jake
    Beeson, James G.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (32) : 14378 - 14383
  • [10] Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi
    Brooks, CS
    Vuppala, SR
    Jett, AM
    Alitalo, A
    Meri, S
    Akins, DR
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (05) : 3299 - 3308